These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 1316500

  • 1. [Evaluation of 99mTc-PMT delayed imaging in diagnosis of hepatocellular carcinoma].
    Hasegawa Y, Nakano S, Ibuka K, Hashizume T, Noguchi A, Kasugai H, Tanaka S, Inoue A, Kojima J, Fujita M.
    Kaku Igaku; 1992 Mar; 29(3):367-76. PubMed ID: 1316500
    [Abstract] [Full Text] [Related]

  • 2. Specific diagnosis of hepatocellular carcinoma by delayed hepatobiliary imaging.
    Hasegawa Y, Nakano S, Ibuka K, Hashizume T, Noguchi A, Sasaki Y, Imaoka S, Fujita M, Kawamoto S, Kasugai H.
    Cancer; 1986 Jan 15; 57(2):230-6. PubMed ID: 2417674
    [Abstract] [Full Text] [Related]

  • 3. Relationship of uptake of technetium-99m(Sn)-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma to prognosis.
    Hasegawa Y, Nakano S, Hiyama T, Sobue T, Yoshida H, Sasaki Y, Imaoka S, Inoue A, Tanaka S, Kusagai H.
    J Nucl Med; 1991 Feb 15; 32(2):228-35. PubMed ID: 1846910
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of 99mTc-N-pyridoxyl-5-methyltryptophan (99mTc-PMT) in the diagnosis of intrahepatic masses.
    Oyamada H, Yamazaki S, Makuuchi M, Hasegawa H.
    Radioisotopes; 1989 May 15; 38(5):244-51. PubMed ID: 2546192
    [Abstract] [Full Text] [Related]

  • 5. The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agent.
    Hasegawa Y, Nakano S, Ibuka K, Hashizume T, Sasaki Y, Imaoka S, Ishiguro S, Kasugai H, Okano Y, Tanaka S.
    J Nucl Med; 1984 Oct 15; 25(10):1122-6. PubMed ID: 6090618
    [Abstract] [Full Text] [Related]

  • 6. [Delayed Tc-99m-PMT imaging in the specific diagnosis of hepatocellular carcinoma].
    Wu ZM.
    Zhonghua Zhong Liu Za Zhi; 1988 Sep 15; 10(5):360-3. PubMed ID: 2854779
    [Abstract] [Full Text] [Related]

  • 7. Comparison of delayed hepatobiliary imaging using 99mTc-Sn-N-pyridoxyl-5-methyltryptophan and 67Ga-citrate imaging for diagnosis of hepatocellular carcinoma.
    Hasegawa Y, Nakano S, Ishiguro S, Imaoka S, Sasaki Y, Tanaka S, Kasugai H, Kojima J, Ishigami S.
    Eur J Nucl Med; 1988 Sep 15; 14(7-8):414-8. PubMed ID: 2846309
    [Abstract] [Full Text] [Related]

  • 8. [Radionuclear estimation with 99mTc-N-pyridoxyl-5-methyl-tryptophan (PMT) scintigraphy of recurrent hepatocellular carcinoma after non-surgical treatment].
    Matsumoto H, Matsuura M, Sakurai H, Nakajima N, Ito K.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Oct 15; 57(12):805-11. PubMed ID: 9394570
    [Abstract] [Full Text] [Related]

  • 9. [Diagnostic value of 99mTc-PMT delayed hepatobiliary imaging in small hepatocellular carcinoma--an analysis of 62 cases].
    Chen SL.
    Zhonghua Zhong Liu Za Zhi; 1991 Jan 15; 13(1):30-2. PubMed ID: 1653687
    [Abstract] [Full Text] [Related]

  • 10. [Clinical evaluation of 99mTc-(Sn)-N-pyridoxyl-5-methyltryptophan (99mTc-PMT) in diagnosis of hepatoma].
    Hasegawa Y, Nakano S, Noguchi A, Hashizume T, Ibuka K, Sasaki Y, Imaoka M, Kozima J, Ishigami S.
    Kaku Igaku; 1983 Nov 15; 20(9):1355-9. PubMed ID: 6328071
    [No Abstract] [Full Text] [Related]

  • 11. [Scintigraphy using 99mTc-PMT, 99mTc-DEIDA, or 67Ga--detection of hepatocellular carcinoma and its metastasis].
    Hasegawa Y, Nakano S.
    Nihon Rinsho; 1991 Aug 15; 49(8):1858-62. PubMed ID: 1664892
    [No Abstract] [Full Text] [Related]

  • 12. [Usefulness of 99mTc-PMT SPECT and 18F-FDG PET in diagnosing orbital metastasis of hepatocellular carcinoma].
    Hosokawa C, Kawabe J, Okamura T, Kamino T, Ikeda H, Ochi H, Onoyama Y.
    Kaku Igaku; 1994 Oct 15; 31(10):1237-42. PubMed ID: 7807727
    [Abstract] [Full Text] [Related]

  • 13. [Comparative study of nuclear imaging with 99mTc-PMT, B ultrasound and CT in the diagnosis of hepatic tumors].
    Wu ZM.
    Zhonghua Fang She Xue Za Zhi; 1988 Dec 15; 22(6):329-33. PubMed ID: 2855051
    [No Abstract] [Full Text] [Related]

  • 14. Establishing a diagnosis of adrenal metastasis from hepatocellular carcinoma by 99mTc-PMT hepatobiliary scintigraphy.
    Yamashita N, Fukawa M, Imaizumi N, Matsumoto S, Tabuchi M, Hiroyoshi M, Kitahara K, Okushima K, Noda T.
    Surg Today; 1992 Dec 15; 22(6):565-7. PubMed ID: 1335313
    [Abstract] [Full Text] [Related]

  • 15. Analysis of factors affecting uptake of Tc-99m Sn-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma.
    Hasegawa Y, Nakano S, Sobue T, Fujita M, Ishiguro S, Sasaki Y, Imaoka S, Tanaka S, Kasugai H, Inoue A.
    Ann Nucl Med; 1994 May 15; 8(2):139-45. PubMed ID: 7521195
    [Abstract] [Full Text] [Related]

  • 16. A new synthetic method for 99mTc labeled N-pyridoxyl-5-methyltryptophan as a hepatoma imaging agent.
    Zhou YG, Zhu T, Zhao HY, Wu ZM, Shi QX, Liang FH.
    Int J Rad Appl Instrum B; 1987 May 15; 14(5):467-73. PubMed ID: 2822632
    [Abstract] [Full Text] [Related]

  • 17. [The utility of quantitative 99mTc-GSA liver scintigraphy in the evaluation of hepatic functional reserve: comparison with 99mTc-PMT and 99mTc-Sn colloid].
    Shuke N, Aburano T, Nakajima K, Yokoyama K, Sun BF, Matsuda H, Muramori A, Michigishi T, Tonami N, Hisada K.
    Kaku Igaku; 1992 May 15; 29(5):573-84. PubMed ID: 1434071
    [Abstract] [Full Text] [Related]

  • 18. Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan.
    Kobayashi M, Nakanishi T, Nishi K, Higaki Y, Okudaira H, Ono M, Tsujiuchi T, Mizutani A, Nishii R, Tamai I, Arano Y, Kawai K.
    Nucl Med Biol; 2014 Apr 15; 41(4):338-42. PubMed ID: 24607436
    [Abstract] [Full Text] [Related]

  • 19. Metastasis of hepatocellular carcinoma to the colon demonstrated by Tc-99m PMT scintigraphy.
    Fukui H, Kashiwagi T, Shirai Y, Matsuda Y, Kawata S, Nishimura T, Kozuka T.
    Clin Nucl Med; 1993 Jun 15; 18(6):512-5. PubMed ID: 8391407
    [Abstract] [Full Text] [Related]

  • 20. Concentration of 99mTc-Sn-N-pyridoxyl-5-methyltryptophan, a biliary agent, in distant metastases of hepatomas.
    Hasegawa Y, Nakano S, Ibuka K, Hashizume T, Sasaki Y, Imaoka S, Ishiguro S, Tanaka S, Kasugai H, Okano Y.
    Eur J Nucl Med; 1985 Jun 15; 10(5-6):255-8. PubMed ID: 2985390
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.